PICH, Achille
 Distribuzione geografica
Continente #
EU - Europa 16.647
NA - Nord America 6.649
AS - Asia 2.599
AF - Africa 56
SA - Sud America 43
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 26.035
Nazione #
IT - Italia 11.685
US - Stati Uniti d'America 6.488
CN - Cina 1.182
UA - Ucraina 830
DE - Germania 686
IE - Irlanda 665
FR - Francia 648
SG - Singapore 563
SE - Svezia 482
FI - Finlandia 415
KR - Corea 346
GB - Regno Unito 327
PL - Polonia 236
DK - Danimarca 166
JP - Giappone 147
CA - Canada 137
NL - Olanda 122
VN - Vietnam 105
AT - Austria 88
CH - Svizzera 72
IN - India 69
ES - Italia 48
TR - Turchia 41
BE - Belgio 36
SN - Senegal 36
ID - Indonesia 31
RU - Federazione Russa 29
AU - Australia 25
HK - Hong Kong 23
MX - Messico 20
BR - Brasile 18
IR - Iran 18
RO - Romania 16
EU - Europa 15
GR - Grecia 14
TW - Taiwan 13
NO - Norvegia 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
PT - Portogallo 11
QA - Qatar 10
CO - Colombia 9
CL - Cile 8
IL - Israele 8
AL - Albania 7
EG - Egitto 7
MY - Malesia 7
HR - Croazia 6
SK - Slovacchia (Repubblica Slovacca) 6
SM - San Marino 6
BY - Bielorussia 5
KW - Kuwait 5
PH - Filippine 5
PK - Pakistan 5
SD - Sudan 5
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
EE - Estonia 3
ZA - Sudafrica 3
DZ - Algeria 2
EC - Ecuador 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
SA - Arabia Saudita 2
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
HU - Ungheria 1
IM - Isola di Man 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
Totale 26.035
Città #
Beijing 848
Milan 793
Dublin 662
Rome 606
Chandler 569
Santa Clara 512
Jacksonville 493
Singapore 459
Houston 311
Medford 259
Fairfield 236
Villeurbanne 224
Torino 212
Ann Arbor 208
Princeton 203
Warsaw 196
Ashburn 192
Wilmington 181
Columbus 180
Dearborn 170
Nyköping 154
Florence 152
Turin 150
Naples 144
Palermo 129
Bologna 108
Verona 106
Woodbridge 105
Pisa 100
Bari 95
Redwood City 95
Catania 93
Los Angeles 90
Seattle 89
Cambridge 85
Vienna 81
Toronto 80
Dong Ket 70
Padova 67
Boston 58
Napoli 54
Genoa 53
Perugia 51
Brescia 49
Tokyo 46
Fremont 43
Lachine 43
Boardman 41
Parma 38
Dallas 37
Falls Church 35
Genova 35
Guangzhou 35
Trieste 35
Modena 34
Pescara 33
Shanghai 33
Cagliari 29
Mountain View 29
Norwalk 29
Rimini 29
Livorno 26
Bergamo 25
Nanjing 25
Jakarta 24
Messina 23
Monza 23
Vicenza 23
Helsinki 22
Taranto 22
Treviso 20
Busto Arsizio 19
San Mateo 19
Zurich 19
Latina 18
New York 18
Reggio Emilia 18
Zhengzhou 17
Brussels 16
Mumbai 16
Ravenna 16
Hefei 15
Sassari 15
Ancona 14
Como 14
Lucca 14
Pune 14
Hangzhou 13
Spoltore 13
Trento 13
Venezia 13
Jesi 12
Paris 12
Prato 12
Reggio Calabria 12
San Diego 12
San Giuliano Milanese 12
Siena 12
Altamura 11
Bolzano 11
Totale 11.029
Nome #
Nevo blu cellulare maligno 8.736
L’attività proliferativa nei tumori del capo-collo. 2.567
Significato degli AgNORs in patologia tumorale. 453
Core binding factor acute myeloid leukaemia and c-KIT mutations 415
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. 350
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia 345
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study. 286
Novel CALR somatic mutations in essential thrombocythaemia 243
Myelodysplastic syndrome with del (5q) and JAK2V617F mutation transformed to acute myeloid leukaemia with complex karyotype 230
Essential Differences in Clinical and Bone Marrow Features in BCR/ABL- Positive Thrombocythemia Compared to Thrombocythemia in the BCR/ABL -Negative Myeloproliferative Neoplasms Essential Thrombocythemia and Polycythemia Vera. 212
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia 204
Prognostic relevance of cell proliferation in head and neck tumors 196
WHO Clinical Molecular and Pathological (WHO-CMP) Features of Congenital MPLS505N and the Acquired MPL W515l/K Mutated Essential Thrombocythemia and Myelofibrosis 183
JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia 180
Significato prognostico della attività proliferativa, valutata con conteggio delle regioni organizzatrici del nucleolo (NORs), nella leucemia acuta mieloblastica (LAM) dell’adulto 165
Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET). 158
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 152
Chronic myelomonocytic leukaemia with marked thrombocytosis and JAK2V617F mutation transformed into an acute megakaryoblastic leukaemia. 147
Nevo Blu Cellulare Neuro neuroide 140
Utilità della citologia esfoliativa orale per la diagnosi di displasia e carcinoma squamoso orale: confronto tra esame citologico tradizionale ed in fase liquida (“Strato sottile”). 139
KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors 139
Core binding factor acute myeloid leukemia and c-kit mutations 129
EFFECT ON CLINICAL OUTCOME OF BONE MARROW RETICULIN FIBROSIS IN 579 PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA 129
Sopravvivenza di soggetti affetti da mieloma in relazione al quadro istologico osteo-midollare 126
Neoplasie papillari superficiali della vescica. Parametri morfologici e biologici correlati con recidive 122
Prognostic value of the rapidity of bone marrow blast cell proliferation in adult acute lymphoblastic leukemia 118
Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study 114
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 114
Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia 111
Refractory cytopenia with multilinear dysplasia (RCMD) in patient with Fanconi anaemia 108
Linfomi non-Hodgkin di piccole cellule primitivi della milza: infiltrazione midollare intrasinusoidale come modalità caratteristica di invasione 105
Autosomal Dominant Hereditary Essential Thrombocythemia due to a Gain of Function Mutation in the Thrombopoietin (TPO) and JAK2 Gene as the Cause of Congenital Aspirin-Responsive Sticky Platelet Syndrome: Personal Experiences and Review of the Literature 102
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. 98
LAT (linker for activation of T cells): un utile marcatore per l’identificazione di megacariociti in biopsie osteomidollari. 93
Myelodysplastic syndrome with isolated del (5q) and JAK2V617F mutation transformed into an acute myeloid leukemia. 93
Parametri biologici di malignità nei linfomi di piccole cellule CD5 positivi 92
Correlative studies on the presence of oestrogen and prolactin receptors and histology in human breast carcinomas 92
Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. 91
Bcl-2 expression in male breast carcinoma. 88
Angiogenic activity of hyperplastic and neoplastic lymph nodes 87
Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma 87
Gli AgNOR in citologia esfoliativa orale 87
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 87
Utilità diagnostica del conteggio degli Organizzatori Nucleolari nella valutazione citologica dei versamenti neoplastici 86
JAK2 V617F activating mutation in chronic myelomonocytic leukemia 86
Prognostic value of nucleolar organizer region count in non-invasive thymomas 86
Significato prognostico degli organizzatori nucleolari (AgNORs) nei carcinomi del seno piriforme 85
AgNORs, nuclear and nucleolar morphometry in prostate carcinoma 82
L'osteodistrofia uremica: correlazione tra dati clinici, radiologici ed istologici in un gruppo di pazienti 81
Studio istologico dei fenomeni riparativi di ulcere distrofiche trattate con Ossigeno ad alte dosi 81
Clinical significance of AgNOR counts in adult acute non-lymphoblastic leukaemia 80
AgNORs and myeloma prognosis. 80
Attività proliferativa di carcinomi di epitelio transizionale della vescica indagata mediante l'analisi degli Organizzatori Nucleolari e la marcatura con l'anticorpo monoclonale anti PCNA (PC10) 80
Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. 79
JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA 79
Prognostic relevance of AgNORs in tumor pathology 79
Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. 79
Attività proliferativa dei carcinomi renali e vescicali indagata mediante l'anticorpo monoclonale Ki67 e l'analisi degli organizzatori nucleolari 78
Prognostic value of AgNORs in renal cell carcinoma: results of a prospective study 78
Significato delle AgNOR in patologia tumorale. 77
Anatomia Patologica 77
Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus. 76
Estensione della coilocitosi e positività immunoistochimica per il virus del papilloma in biopsie di condilomi della cervice uterina 75
Androgen receptors in male breast carcinoma 75
Follow-up of 24 cervical condylomata immunocytochemically positive for PV-Ag according to the virus type 75
p53 protein expression in patients with myelodysplasia treated with allogeneic bone marrow transplantation 75
Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma 75
Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm. 74
Autopsy and multiple pathology in the elderly 74
Acute myelofibrosis and megakaryoblastic leukemia: an immunohistochemical study on bone marrow trephine biopsies 74
Alterazioni istologiche del midollo osseo nei pazienti affetti da insufficienza renale cronica sottoposti a dialisi 74
Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma 73
Angiogenesi indotta da tessuto linfatico neoplastico evidenziata con impianto irideo. 73
[Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies] 73
Authors response to Tripodo et al. "Reply to Pich et al.: Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study." 71
Quantitative analysis of WT1 gene transcripts in adult acute leukemia 71
DNA Flow Cytometry, Ki67 and Proliferating Cell Nuclear Antigen (PCNA-PC10) scores in intermediate grade malignant lymphomas 71
The diagnostic value of histological findings in cervical condylomata immunohistochemically positive for papilloma virus (HPV) 71
Argyrophilic nucleolar organizer region counts predict survival in thymoma. 71
Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma 71
Prognostic value of AgNOR counting. A prospective study in a series of renal cell carcinomas. 71
Persistenza della positività immunoistochimica per il virus del papilloma umano (HPV) in condilomi piani della porzione vaginale della cervice uterina ricontrollati a distanza di tempo 70
Nucleolar organiser regions in bone marrow biopsies of patients with acute myelogeneous leukaemia 70
Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma. 70
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies 70
Creation of an experimental model of antro-jejunal and antro-colic transposition in rats 69
A computer network-based system for local storage and nationwide processing of autopsy diagnoses 68
Attività proliferativa di linfomi maligni di gruppo intermedio valutata con l'analisi del DNA e la marcatura con gli anticorpi monoclonali Ki67 e anti PCNA (PC10) 68
In male breast carcinoma DNA flowcytometric ploidy correlates with proliferative activity and prognosis 68
JAK2V617F, CALR and MPL mutations and bone marrow histology in patients with essential thrombocythemia. 68
Discrasie delle plasmacellule e gammopatie 67
Experimental investigation on histocompatibility of bovine collagen in rat tongue 67
Proliferative activity is a significant prognostic factor in male breast carcinoma. 67
JAK2V617F mutation and allele burden in patients with essential thrombocythemia 67
In patients with Polycythemia Vera older age is the prognostic factor at highest impact on survival 67
Valutazione dell'attività Timidina-chinasica nei liquidi di versamenti come controllo dell'accuratezza diagnostica citologica 67
Analysis of nucleolar organizer regions is predictive of complete remission in patients with acute myeloid leukemia 66
Bone marrow histopathology and prognosis in malignant lymphomas. 66
Argyrophilic nucleolar organizer regions (AgNORs) counts, proliferating cell nuclear antigen (PCNA) scores and DNA flow cytometry of bladder urotheliomas in routinely treated biopsies 66
AgNOR proliferation index and development of hepatocellular carcinoma in cirrhosis 65
Totale 22.115
Categoria #
all - tutte 53.805
article - articoli 0
book - libri 0
conference - conferenze 28.457
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.969 0 0 0 0 0 402 345 208 365 179 266 204
2020/20213.110 380 156 284 171 240 178 295 141 398 292 231 344
2021/20222.353 174 141 140 149 131 114 192 156 133 139 335 549
2022/20233.585 360 194 140 285 292 753 357 275 345 130 220 234
2023/20242.892 279 234 103 146 112 147 275 162 52 317 449 616
2024/20253.393 462 762 379 602 842 346 0 0 0 0 0 0
Totale 26.610